Althuwaikh Sulaiman, Albassam Ibrahim, Alrashed Abdulrahaman, Alhaji Fahad, Al-Adawi Ahmed, Sindi Mohammed A, Alhibshi Ahmad, Al Dehaini Ahmad, Alqaysi Layal
Internal Medicine, Al-Amiri Hospital, Kuwait City, KWT.
Internal Medicine, Lincoln County Hospital, Lincoln, GBR.
Cureus. 2023 Sep 23;15(9):e45834. doi: 10.7759/cureus.45834. eCollection 2023 Sep.
Despite significant pharmacological advancements, hypertension management remains challenging, with varying quality of primary care. Digital tools and other non-pharmacological interventions hold promise in addressing this challenge. Consequently, a thorough examination of these interventions is recommended. This meta-analysis focuses on clinician-oriented strategies aimed at improving hypertension management, to assess the most effective approaches for improving antihypertensive prescribing and blood pressure control for secondary prevention. This was done through a systematic review of randomized controlled trials published in PubMed and Embase since the beginning of 2010 that aimed to enhance antihypertensive medication prescription in primary care settings for hypertensive patients with secondary complications while reporting changes in blood pressure or target achievement. We screened 6305 records. Four studies met the inclusion criteria, with reported interventions including physician education and the implementation of electronic decision support systems. All studies showed that the control group had a statistically significant lower systolic blood pressure, but the effect on diastolic blood pressure was not statistically significant. The overall mean difference was 2.12 mmHg (95% CI = 0.98; 3.26, P-value = 0.0003) for systolic blood pressure in favor of the control group and 1.22 mmHg (95% CI = -0.48; 3.26, P-value = 0.16) for diastolic blood pressure, which was not statistically significant. Despite considerable efforts to control hypertension, it remains a significant obstacle to optimal cardiovascular risk reduction. This review is also limited by a scarcity of studies.
尽管药理学取得了重大进展,但高血压管理仍然具有挑战性,初级保健质量参差不齐。数字工具和其他非药物干预措施有望应对这一挑战。因此,建议对这些干预措施进行全面审查。本荟萃分析聚焦于旨在改善高血压管理的以临床医生为导向的策略,以评估改善降压处方和二级预防血压控制的最有效方法。这是通过系统回顾自2010年初以来发表在PubMed和Embase上的随机对照试验来完成的,这些试验旨在加强初级保健环境中对患有继发性并发症的高血压患者的降压药物处方,同时报告血压变化或目标达成情况。我们筛选了6305条记录。四项研究符合纳入标准,报告的干预措施包括医生教育和电子决策支持系统的实施。所有研究均表明,对照组的收缩压在统计学上显著更低,但对舒张压的影响无统计学意义。收缩压的总体平均差异为2.12 mmHg(95%置信区间=0.98;3.26,P值=0.0003),有利于对照组,舒张压的总体平均差异为1.22 mmHg(95%置信区间=-0.48;3.26,P值=0.16),无统计学意义。尽管在控制高血压方面付出了巨大努力,但它仍然是实现最佳心血管风险降低的重大障碍。本综述也因研究稀缺而受到限制。